Joiner M C, Johns H
Gray Laboratory, Cancer Research Campaign, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.
Radiat Res. 1988 May;114(2):385-98.
Experiments were undertaken to study the effect on the mouse kidney of repeated X-ray doses in the range 0.2 to 1.6 Gy per fraction and neutron doses in the range 0.05 to 0.25 Gy per fraction. A top-up design of experiment was used, so that additional graded doses of d(4)-Be neutrons (EN = 2.3 MeV) were given to bring the subthreshold damage produced by these treatments into the measurable range. This approach avoided the necessity to use a large number of fractions to study low doses per fraction. Renal damage was assessed using three methods: 51Cr-EDTA clearance, urine output, and hematocrit at 16-50 weeks postirradiation. The dose-response curves obtained were resolved best at 29 weeks. However, the results were also examined by fitting second-order polynomials to the data for response versus time postirradiation and using interpolated values from these functions at 29 weeks to construct dose-response curves. This method reduced slightly the variation in the dose-response data, but the interrelationship between the dose-response curves remained the same. The data were used to test the linear-quadratic (LQ) description of the underlying X-ray dose-fractionation relationship. The model fits well down to X-ray doses per fraction of approximately 1 Gy, but lower X-ray doses were more effective per gray than predicted by LQ, as seen previously in skin [M. C. Joiner et al., Int. J. Radiat. Biol. 49, 565-580 (1986)]. This increased X-ray effectiveness and deviation from LQ are reflected directly in a decrease in the RBE of d(4)-Be neutrons relative to X-rays at low doses, since the underlying response to these neutrons is linear in this low-dose region. The RBE decreases from 9.9 to 4.7 as the X-ray dose per fraction is reduced below 0.8 Gy to 0.2 Gy, reflecting an increase in X-ray effectiveness by a factor of 2.1. A model is discussed which attempts to explain this behavior at low doses per fraction.
开展了实验,以研究每次分割剂量在0.2至1.6 Gy范围内的重复X射线剂量以及每次分割剂量在0.05至0.25 Gy范围内的中子剂量对小鼠肾脏的影响。采用了补充设计实验,以便给予额外的分级剂量的d(4)-Be中子(EN = 2.3 MeV),将这些治疗产生的亚阈值损伤带入可测量范围。这种方法避免了使用大量分割来研究每次分割低剂量的必要性。使用三种方法评估肾脏损伤:51Cr-EDTA清除率、尿量以及照射后16至50周的血细胞比容。所获得的剂量反应曲线在29周时解析效果最佳。然而,还通过将二阶多项式拟合到照射后反应与时间的数据,并使用这些函数在29周时的内插值来构建剂量反应曲线,对结果进行了检查。该方法略微降低了剂量反应数据的变异性,但剂量反应曲线之间的相互关系保持不变。这些数据用于检验潜在的X射线剂量分割关系的线性二次(LQ)描述。该模型在每次分割X射线剂量约为1 Gy时拟合良好,但低于该剂量时,每格雷的X射线比LQ预测的更有效,如先前在皮肤研究中所见[M. C. Joiner等人,《国际辐射生物学杂志》49,565 - 580(1986)]。这种X射线有效性的增加以及与LQ的偏差直接反映在低剂量下d(4)-Be中子相对于X射线的相对生物效应(RBE)降低,因为在这个低剂量区域对这些中子的潜在反应是线性的。当每次分割的X射线剂量从0.8 Gy降至0.2 Gy时,RBE从9.9降至4.7,这反映出X射线有效性增加了2.1倍。讨论了一个试图解释每次分割低剂量时这种行为的模型。